Complete Filing Data
NEUROCRINE BIOSCIENCES INC reported Net Income Loss of $478.60 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NEUROCRINE BIOSCIENCES INC did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $478.6M | $341.3M | $249.7M | $154.5M | $89.6M | $407.3M | $37.0M | $21.1M | -$142.5M | -$141.1M | -$88.9M | -$60.5M | -$46.1M | $5.0M | $37.6M | -$8.0M | -$51.0M |
| Cost of Revenue * | $52.1M | $34.0M | $39.7M | $23.2M | $14.3M | $10.1M | $4.9M | $1.3M | $0.00 | $0.00 | |||||||
| Revenue * | $2.86B | $2.36B | $1.89B | $1.49B | $1.13B | $1.05B | $788.1M | $451.2M | $161.6M | $15.0M | $19.8M | $0.00 | $2.9M | $53.1M | $77.4M | $33.5M | $3.0M |
| Operating Expenses | $1.03B | $882.9M | $715.8M | $414.4M | $293.0M | $162.4M | $114.0M | $64.4M | $52.6M | $51.7M | $43.5M | $47.2M | $56.6M | ||||
| Operating Income Loss | $619.1M | $570.5M | $250.9M | $249.0M | $102.5M | $163.0M | $72.3M | $36.8M | -$131.4M | -$147.4M | -$94.2M | -$64.4M | -$49.7M | $1.4M | $33.9M | -$13.7M | -$53.7M |
| Nonoperating Income Expense | $86.3M | -$84.5M | $81.2M | -$35.1M | -$1.1M | -$56.3M | -$25.8M | -$15.0M | -$11.2M | $6.3M | $5.3M | $3.9M | $3.6M | $3.6M | $3.6M | $5.8M | $2.6M |
| Comprehensive Income Net Of Tax | $485.9M | $340.1M | $264.6M | $148.3M | $86.1M | $407.7M | $40.4M | $21.0M | -$144.1M | -$140.4M | -$89.6M | -$60.8M | -$46.1M | $5.1M | $37.5M | -$9.2M | -$48.3M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$3.5M | $400.0K | $3.4M | -$100.0K | -$1.5M | $659.0K | -$700.0K | -$282.0K | $7.0K | $85.0K | -$39.0K | -$1.3M | $2.8M | ||||
| Selling General And Administrative Expense | $1.16B | $1.01B | $887.6M | $752.7M | $583.3M | $433.3M | $354.1M | $248.9M | $169.9M | $68.1M | $32.5M | ||||||
| Research And Development Expense | $160.5M | $121.8M | $94.3M | $81.5M | $46.4M | $39.2M | $37.2M | $31.0M | $31.2M | $33.7M | |||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $3.5M | -$100.0K | $12.5M | -$9.1M | -$3.5M | $400.0K | $85.0K | -$39.0K | -$1.3M | ||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $705.4M | $486.0M | $332.1M | $213.9M | $101.4M | $106.7M | $46.5M | $21.8M | -$142.5M | -$141.1M | |||||||
| Interest Expense | $4.6M | $7.1M | $25.8M | $32.8M | $32.0M | $30.5M | $19.5M | $0.00 | $0.00 | ||||||||
| Income Tax Expense Benefit | $226.8M | $144.7M | $82.4M | $59.4M | $11.8M | -$300.6M | $9.5M | $700.0K | $0.00 | $0.00 | |||||||
| General And Administrative Expense | $68.1M | $32.5M | $18.0M | $13.3M | $13.4M | $12.5M | $13.3M | $14.4M | |||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $17.4M | $12.5M | $143.9M | $0.00 | $105.3M | $164.5M | $154.3M | $4.8M | $30.0M | ||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $1.02B | $731.1M | $565.0M | $463.8M | $328.1M | $275.0M | |||||||||||
| Other Nonoperating Income Expense | -$20.0K | $21.0K | $20.0K | $18.0K | $16.0K | $14.0K | $36.0K | $1.1M | $457.0K | ||||||||
| Licenses Revenue | $45.0M | $15.0M | $19.8M | $0.00 | $2.9M | $34.2M | $67.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $209.5M | $107.5M | $7.9M | $129.8M | $65.0M | $43.4M | $83.1M | $95.5M | -$76.6M | $68.5M | -$16.9M | $13.9M | $22.5M | $42.3M | $32.1M | $347.9M | -$57.6M | $79.6M | $37.4M | $34.0M | $53.8M | $51.3M | -$102.1M | $18.1M | $50.8M | -$5.9M | -$41.8M | $6.9M | -$11.1M | -$60.0M | -$78.3M | -$44.7M | -$36.9M | -$40.3M | -$19.3M | -$29.3M | -$34.4M | -$24.0M | -$1.2M | -$19.4M | -$15.9M | -$13.4M | -$11.8M | -$10.6M | -$11.1M | -$12.2M | -$12.1M | $9.5M | -$3.1M | -$501.0K | -$886.0K | $1.3M | $31.4M | $2.0M | $2.9M | $3.3M | -$5.2M |
| Cost of Revenue * | $14.0M | $11.3M | $9.2M | $8.0M | $9.2M | $7.5M | $11.2M | $11.5M | $8.5M | $6.1M | $4.8M | $4.6M | $4.2M | $3.1M | $2.9M | $2.7M | $2.4M | $2.1M | $2.2M | $1.6M | $1.1M | $1.6M | $854.0K | $950.0K | $433.0K | $61.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||||||||
| Revenue * | $794.9M | $687.5M | $572.6M | $622.1M | $590.2M | $515.3M | $498.8M | $452.7M | $420.4M | $387.9M | $378.2M | $310.6M | $296.0M | $288.9M | $236.6M | $247.9M | $258.5M | $302.4M | $237.1M | $244.1M | $222.1M | $183.5M | $138.4M | $131.5M | $151.8M | $96.9M | $71.1M | $94.5M | $60.8M | $6.3M | $0.00 | $0.00 | $0.00 | $0.00 | $15.0M | $0.00 | $0.00 | $0.00 | $19.8M | $0.00 | $0.00 | $0.00 | $0.00 | $730.0K | $729.0K | $730.0K | $730.0K | $21.9M | $9.4M | $10.6M | $11.3M | $11.1M | $41.6M | $12.2M | $12.5M | $14.4M | $4.6M |
| Operating Expenses | $176.1M | $302.8M | $225.8M | $178.2M | $195.3M | $132.0M | $149.1M | $239.4M | $109.6M | $97.4M | $98.8M | $108.5M | $82.7M | $66.8M | $63.6M | $79.9M | $46.3M | $38.4M | $41.8M | $35.9M | $30.7M | $35.8M | $25.3M | $22.1M | $20.5M | $16.9M | $14.4M | $12.7M | $12.3M | $12.7M | $13.9M | $13.7M | $13.4M | $13.3M | $11.9M | $13.1M | $10.7M | $11.2M | $11.1M | $10.6M | $12.0M | $10.5M | |||||||||||||||
| Operating Income Loss | $239.0M | $145.6M | $23.6M | $183.8M | $145.4M | $99.3M | $141.2M | $73.6M | -$114.2M | $87.8M | $54.7M | $3.1M | $44.5M | $62.8M | $31.5M | -$44.3M | $76.6M | $58.9M | $90.1M | $34.4M | -$101.0M | $54.3M | -$1.9M | -$37.4M | -$6.0M | -$57.3M | -$79.9M | -$38.4M | -$41.8M | -$20.9M | -$35.8M | -$25.3M | -$2.3M | -$16.9M | -$14.4M | -$12.7M | -$12.0M | -$13.2M | -$13.0M | -$4.0M | -$1.4M | -$1.8M | $30.4M | $1.1M | $1.9M | $2.5M | -$5.9M | ||||||||||
| Nonoperating Income Expense | $52.8M | $13.9M | -$8.9M | $6.5M | -$46.8M | -$64.8M | -$25.6M | $48.0M | $10.9M | $10.1M | -$78.0M | $18.3M | -$14.0M | -$5.3M | -$4.3M | -$12.8M | $6.6M | -$20.0M | -$31.7M | $17.7M | -$1.6M | -$3.6M | -$4.1M | -$4.4M | -$5.1M | -$2.7M | $1.6M | $1.5M | $1.5M | $1.6M | $1.4M | $1.3M | $1.1M | $982.0K | $980.0K | $883.0K | $875.0K | $925.0K | $900.0K | $884.0K | $879.0K | $906.0K | $942.0K | $880.0K | $943.0K | $867.0K | $738.0K | ||||||||||
| Comprehensive Income Net Of Tax | $210.2M | $111.0M | $11.1M | $141.8M | $64.2M | $39.7M | $82.5M | $97.1M | -$71.4M | $66.7M | -$19.8M | $6.3M | $22.2M | $42.0M | $31.3M | -$59.0M | $85.6M | $34.6M | $54.8M | $52.2M | -$100.4M | $51.5M | -$5.0M | -$43.7M | -$10.9M | -$60.5M | -$78.2M | -$37.0M | -$40.1M | -$18.5M | -$34.6M | -$24.2M | -$1.1M | -$16.0M | -$13.3M | -$12.0M | -$11.1M | -$12.2M | -$12.1M | -$2.9M | -$517.0K | -$926.0K | $31.2M | $2.0M | $2.9M | ||||||||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$600.0K | $1.6M | $5.2M | -$1.8M | -$2.9M | -$7.6M | -$300.0K | -$300.0K | -$800.0K | -$1.4M | $6.0M | -$2.8M | $1.0M | $900.0K | $1.7M | $753.0K | $888.0K | -$1.8M | $179.0K | -$478.0K | $83.0K | -$148.0K | $149.0K | $789.0K | -$205.0K | -$225.0K | $98.0K | -$81.0K | $68.0K | -$199.0K | $35.0K | $0.00 | -$42.0K | -$40.0K | -$2.0K | ||||||||||||||||||||||
| Selling General And Administrative Expense | $291.6M | $286.3M | $276.5M | $234.3M | $242.0M | $243.1M | $204.2M | $221.8M | $242.7M | $186.3M | $182.8M | $200.7M | $154.6M | $143.2M | $129.0M | $112.5M | $96.5M | $117.8M | $84.5M | $80.8M | $87.5M | $60.4M | $60.9M | $58.6M | $43.9M | $41.7M | $28.1M | $17.5M | $15.0M | ||||||||||||||||||||||||||||
| Research And Development Expense | $73.2M | $58.3M | $61.7M | $37.7M | $35.5M | $37.0M | $48.9M | $22.5M | $21.9M | $51.9M | $20.9M | $26.9M | $23.9M | $24.4M | $18.7M | $16.6M | $12.2M | $10.2M | $8.6M | $9.5M | $10.5M | $10.3M | $9.9M | $8.8M | $9.4M | $7.5M | $8.2M | $7.3M | $8.2M | $7.3M | |||||||||||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | -$900.0K | $2.7M | $1.7M | $9.1M | -$900.0K | -$3.2M | $800.0K | $700.0K | $4.0M | -$1.8M | -$2.9M | -$7.6M | -$300.0K | -$300.0K | -$800.0K | -$1.4M | $6.0M | -$2.8M | $1.0M | $900.0K | $1.7M | $753.0K | $888.0K | -$1.8M | $35.0K | -$42.0K | $162.0K | -$16.0K | -$40.0K | -$140.0K | $31.0K | ||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $291.8M | $159.5M | $14.7M | $190.3M | $98.6M | $34.5M | $115.6M | $121.6M | -$103.3M | $97.9M | -$23.3M | $21.4M | $30.5M | $57.5M | $27.2M | -$57.1M | $83.2M | $38.9M | $58.4M | $52.1M | -$102.6M | $50.8M | -$5.9M | -$41.8M | |||||||||||||||||||||||||||||||||
| Interest Expense | $1.1M | $1.1M | $1.3M | $1.1M | $1.2M | $2.2M | $2.6M | $6.6M | $6.2M | $6.4M | $8.5M | $8.3M | $8.2M | $8.0M | $7.9M | $7.9M | $7.7M | $7.6M | $7.5M | $7.3M | $4.8M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||||||
| Income Tax Expense Benefit | $82.3M | $52.0M | $6.8M | $60.5M | $33.6M | -$8.9M | $32.5M | $26.1M | -$26.7M | $29.4M | -$6.4M | $7.5M | $8.0M | $15.2M | -$4.9M | $500.0K | $3.6M | $1.5M | $4.6M | $800.0K | -$500.0K | ||||||||||||||||||||||||||||||||||||
| General And Administrative Expense | $28.1M | $17.5M | $15.0M | $12.0M | $11.5M | $6.6M | $5.5M | $4.7M | $4.2M | $4.2M | $3.2M | $3.4M | $3.4M | $3.3M | $3.1M | $3.7M | $3.8M | $2.8M | $3.2M | $3.6M | $3.1M | ||||||||||||||||||||||||||||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $300.0K | $0.00 | $100.0K | $1.0M | $2.5M | $6.0M | $0.00 | $0.00 | $143.9M | $0.00 | $0.00 | $0.00 | $0.00 | $5.0M | $118.5M | $46.0M | $0.00 | $5.0M | $113.1M | ||||||||||||||||||||||||||||||||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $250.0M | $244.3M | $263.2M | $195.0M | $191.1M | $159.4M | $142.2M | $145.8M | $139.5M | $107.7M | $135.9M | $102.2M | $92.7M | $74.8M | $73.2M | $69.1M | $80.9M | $45.3M | $61.7M | ||||||||||||||||||||||||||||||||||||||
| Other Nonoperating Income Expense | $0.00 | $0.00 | $0.00 | $3.0K | $0.00 | -$5.0K | $4.0K | $2.0K | $2.0K | $5.0K | $2.0K | $18.0K | $5.0K | $8.0K | $35.0K | ||||||||||||||||||||||||||||||||||||||||||
| Licenses Revenue | $15.0M | $0.00 | $0.00 | $0.00 | $0.00 | $15.0M | $0.00 | $0.00 | $19.8M | $0.00 | $0.00 | $0.00 | $729.0K | $730.0K | $730.0K | $8.0M | $9.0M | $9.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.25B | $2.59B | $2.23B | $1.71B | $1.37B | $1.13B | $636.9M | $480.8M | $372.2M | $314.9M | $424.5M | $208.7M | $120.4M | $154.4M | $60.1M | $19.3M | $4.0M | $36.8M |
| Cash And Cash Equivalents At Carrying Value | $713.0M | $233.0M | $251.1M | $262.9M | $340.8M | $187.1M | $112.3M | $141.7M | $254.7M | $83.3M | $74.2M | $31.0M | $44.8M | $63.8M | $50.1M | $54.1M | $37.3M | $68.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $721.0M | $241.0M | $259.1M | $270.7M | $344.0M | $190.3M | $115.5M | $147.2M | $259.2M | $88.2M | $79.0M | |||||||
| Retained Earnings Accumulated Deficit | $447.7M | $29.2M | -$157.1M | -$406.8M | -$635.8M | -$725.4M | -$1.13B | -$1.18B | -$1.20B | -$1.06B | -$915.2M | -$826.3M | -$765.8M | -$719.7M | -$724.7M | -$762.3M | ||
| Property Plant And Equipment Net | $89.8M | $82.6M | $70.8M | $58.6M | $58.6M | $44.6M | $41.9M | $33.9M | $10.8M | $6.3M | $3.4M | $2.5M | $1.8M | $1.9M | $1.6M | $1.5M | ||
| Liabilities Current | $743.4M | $507.7M | $654.8M | $537.7M | $245.8M | $186.5M | $565.3M | $88.2M | $54.4M | $30.4M | $25.7M | $15.7M | $11.7M | $15.6M | $47.1M | $52.8M | ||
| Liabilities And Stockholders Equity | $4.63B | $3.72B | $3.25B | $2.37B | $2.07B | $1.73B | $1.31B | $993.2M | $817.6M | $365.1M | $474.8M | $243.0M | $154.7M | $196.0M | $138.4M | $144.4M | ||
| Liabilities | $1.38B | $1.13B | $1.02B | $660.9M | $698.5M | $608.5M | $669.1M | $512.4M | $445.5M | $50.2M | $50.3M | $34.3M | $34.3M | $41.6M | $78.3M | $125.1M | ||
| Common Stock Value | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $91.0K | $89.0K | $87.0K | $86.0K | $76.0K | $67.0K | $66.0K | $55.0K | $55.0K | ||
| Assets Current | $2.52B | $1.72B | $1.61B | $1.45B | $972.8M | $1.02B | $831.0M | $737.8M | $554.9M | $310.4M | $384.1M | $198.2M | $148.5M | $189.3M | $132.5M | $133.1M | ||
| Assets | $4.63B | $3.72B | $3.25B | $2.37B | $2.07B | $1.73B | $1.31B | $993.2M | $817.6M | $365.1M | $474.8M | $243.0M | $154.7M | $196.0M | $138.4M | $144.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $13.1M | $5.8M | $7.0M | -$7.9M | -$1.7M | $1.8M | $1.4M | -$1.9M | -$1.9M | -$318.0K | -$977.0K | -$277.0K | $5.0K | -$2.0K | -$87.0K | -$48.0K | ||
| Other Assets Current | $115.8M | $63.6M | $97.8M | $79.1M | $45.5M | $30.1M | $16.6M | $18.6M | $6.8M | $3.1M | $4.9M | $4.4M | $2.7M | $2.2M | $1.5M | $1.7M | ||
| Other Liabilities Noncurrent | $219.7M | $166.2M | $106.3M | $29.7M | $12.3M | $9.7M | $17.1M | $35.7M | $0.00 | $113.0K | $221.0K | $260.0K | $260.0K | $152.0K | $125.0K | $101.0K | ||
| Accretion Amortization Of Discounts And Premiums Investments | $12.7M | $26.2M | $18.3M | -$3.7M | -$7.4M | $2.0M | -$1.4M | -$1.8M | -$3.5M | -$6.0M | -$3.8M | -$2.8M | -$3.1M | -$2.3M | -$833.0K | |||
| Deferred Gain On Sale Of Real Estate | $2.1M | $3.4M | $3.3M | $3.2M | $3.1M | $3.0M | $3.0M | $2.9M | $2.8M | |||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Additional Paid In Capital Common Stock | $2.79B | $2.55B | $2.38B | $2.12B | $2.01B | $1.85B | $1.77B | $1.66B | $1.57B | $1.37B | $1.34B | $1.04B | ||||||
| Equity Securities Fv Ni Unrealized Gain Loss | -$4.0M | -$37.1M | $28.4M | $30.8M | $20.9M | -$17.7M | -$13.0M | $0.00 | $0.00 | |||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $3.2M | $5.5M | $4.5M | $4.9M | $4.8M | $4.8M | $4.4M | $4.3M | $4.3M | $6.1M | ||||||||
| Accounts Payable And Accrued Liabilities Current | $674.3M | $461.6M | $448.8M | $347.6M | $225.8M | $168.7M | $141.3M | $86.4M | $53.5M | $26.2M | ||||||||
| Accounts Receivable Net Current | $686.8M | $479.1M | $439.3M | $185.5M | $157.1M | $126.6M | $57.4M | $31.1M | $0.00 | |||||||||
| Other Liabilities Current | $69.1M | $46.1M | $35.9M | $20.7M | $20.0M | $17.8M | $15.2M | $1.9M | $906.0K | $0.00 | ||||||||
| Deferred Rent Credit Noncurrent | $3.1M | $1.5M | $1.7M | $1.9M | $2.0M | $1.8M | $1.8M | $1.4M | ||||||||||
| Deferred Gain On Sale Of Real Estate Noncurrent | $8.0M | $7.4M | $10.9M | $14.3M | $17.6M | $20.9M | $24.0M | $27.0M | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $480.0M | -$18.1M | -$11.6M | -$73.3M | $153.7M | $74.8M | -$31.7M | -$112.0M | $171.1M | $9.2M | ||||||||
| Other Operating Activities Cash Flow Statement | $700.0K | $100.0K | $700.0K | $1.6M | -$3.0M | $3.7M | -$1.2M | $1.0M | -$1.4M | |||||||||
| Gains Losses On Sales Of Assets | $760.0K | $2.1M | $3.4M | $3.3M | $3.2M | $3.2M | $3.1M | $3.2M | $3.2M | $3.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.00B | $2.69B | $2.54B | $2.72B | $2.51B | $2.39B | $2.00B | $1.85B | $1.68B | $1.54B | $1.42B | $1.39B | $1.35B | $1.28B | $1.21B | $804.3M | $831.2M | $700.3M | $574.5M | $483.7M | $409.3M | $447.5M | $377.4M | $364.5M | $347.5M | $345.2M | $247.1M | $351.7M | $381.0M | $413.0M | $446.9M | $466.9M | $484.7M | $224.0M | $236.8M | $247.1M | $129.3M | $136.0M | $145.0M | $143.3M | $144.7M | $143.8M | $57.7M | $25.6M | ||||||
| Cash And Cash Equivalents At Carrying Value | $340.2M | $264.0M | $194.1M | $349.1M | $139.7M | $396.3M | $293.7M | $160.2M | $103.8M | $212.2M | $163.3M | $270.2M | $311.1M | $368.0M | $352.6M | $425.3M | $415.1M | $187.0M | $166.6M | $141.0M | $72.8M | $195.7M | $166.4M | $175.3M | $267.8M | $309.5M | $64.1M | $99.8M | $86.2M | $115.3M | $66.4M | $132.1M | $170.3M | $29.0M | $37.4M | $105.5M | $34.9M | $44.3M | $31.6M | $44.5M | $42.0M | $76.9M | $39.5M | $18.8M | $24.4M | $77.3M | $95.1M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $348.2M | $272.0M | $202.1M | $357.1M | $147.7M | $404.3M | $301.7M | $168.2M | $111.6M | $220.0M | $171.1M | $278.0M | $314.3M | $371.2M | $355.8M | $428.5M | $418.3M | $190.2M | $171.8M | $146.5M | $78.3M | $201.2M | $171.9M | $179.8M | $272.4M | $314.1M | $69.2M | |||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | $294.0M | $84.5M | -$5.3M | $81.1M | -$48.7M | -$113.7M | -$304.8M | -$387.9M | -$483.4M | -$495.8M | -$564.3M | -$547.4M | -$628.5M | -$651.0M | -$693.3M | -$1.07B | -$1.02B | -$1.10B | -$1.17B | -$1.22B | -$1.27B | -$1.20B | -$1.25B | -$1.24B | -$1.21B | -$1.19B | -$1.13B | -$1.01B | -$974.8M | -$934.5M | -$885.9M | -$851.5M | -$827.5M | -$806.9M | -$791.0M | -$777.6M | -$755.1M | -$744.0M | -$731.7M | -$729.2M | -$726.1M | -$725.6M | -$726.0M | -$757.4M | ||||||
| Property Plant And Equipment Net | $97.3M | $91.7M | $87.0M | $80.0M | $80.1M | $75.3M | $68.8M | $65.6M | $62.8M | $60.9M | $66.8M | $63.9M | $51.1M | $50.0M | $45.3M | $43.0M | $44.6M | $41.9M | $40.3M | $39.6M | $36.7M | $28.6M | $18.8M | $11.8M | $9.1M | $7.0M | $7.1M | $6.2M | $5.8M | $3.9M | $2.9M | $2.8M | $2.5M | $2.3M | $2.2M | $1.8M | $1.7M | $1.9M | $1.8M | $2.0M | $1.9M | $1.8M | $1.7M | $1.3M | ||||||
| Liabilities Current | $638.0M | $546.3M | $522.9M | $429.7M | $398.5M | $712.9M | $691.6M | $582.5M | $374.1M | $485.1M | $285.7M | $253.5M | $225.9M | $212.9M | $190.0M | $611.0M | $573.0M | $140.3M | $115.7M | $100.6M | $72.0M | $456.4M | $61.8M | $46.5M | $38.1M | $27.7M | $23.6M | $26.7M | $26.9M | $23.3M | $19.8M | $17.6M | $15.2M | $14.0M | $12.1M | $10.6M | $13.3M | $14.6M | $13.9M | $23.1M | $29.2M | $36.6M | $48.4M | $50.0M | ||||||
| Liabilities And Stockholders Equity | $4.27B | $3.89B | $3.69B | $3.54B | $3.31B | $3.47B | $2.85B | $2.61B | $2.36B | $2.14B | $2.01B | $2.14B | $2.02B | $1.96B | $1.85B | $1.50B | $1.52B | $1.36B | $1.18B | $1.07B | $957.7M | $933.7M | $841.3M | $806.4M | $772.5M | $754.1M | $289.4M | $399.2M | $429.8M | $459.3M | $492.4M | $511.2M | $527.8M | $257.8M | $269.5M | $279.3M | $166.0M | $174.8M | $183.9M | $193.3M | $202.1M | $210.1M | $149.0M | $127.4M | ||||||
| Liabilities | $1.26B | $1.20B | $1.15B | $816.1M | $795.8M | $1.09B | $846.1M | $760.1M | $675.3M | $598.8M | $582.3M | $753.4M | $671.3M | $677.2M | $640.8M | $698.3M | $684.4M | $661.6M | $605.4M | $583.2M | $548.4M | $486.2M | $463.9M | $441.9M | $425.0M | $408.8M | $42.2M | $47.5M | $48.8M | $46.4M | $45.5M | $44.3M | $43.0M | $33.7M | $32.7M | $32.2M | $36.7M | $38.8M | $39.0M | $49.9M | $57.4M | $66.3M | $91.3M | $101.8M | ||||||
| Common Stock Value | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $92.0K | $92.0K | $91.0K | $91.0K | $90.0K | $90.0K | $88.0K | $88.0K | $88.0K | $87.0K | $87.0K | $87.0K | $86.0K | $86.0K | $85.0K | $76.0K | $76.0K | $76.0K | $67.0K | $67.0K | $67.0K | $66.0K | $66.0K | $66.0K | $55.0K | $55.0K | ||||||
| Assets Current | $2.16B | $1.75B | $1.64B | $1.88B | $1.67B | $1.80B | $1.65B | $1.50B | $1.43B | $1.21B | $1.02B | $1.02B | $1.01B | $1.11B | $1.09B | $1.16B | $1.15B | $968.2M | $819.2M | $748.8M | $633.2M | $714.4M | $567.7M | $513.7M | $548.5M | $536.8M | $239.5M | $357.9M | $392.0M | $401.0M | $382.8M | $389.4M | $405.0M | $183.9M | $197.6M | $221.7M | $159.2M | $155.9M | $160.4M | $178.0M | $181.3M | $185.0M | $136.1M | $120.0M | ||||||
| Assets | $4.27B | $3.89B | $3.69B | $3.54B | $3.31B | $3.47B | $2.85B | $2.61B | $2.36B | $2.14B | $2.01B | $2.14B | $2.02B | $1.96B | $1.85B | $1.50B | $1.52B | $1.36B | $1.18B | $1.07B | $957.7M | $933.7M | $841.3M | $806.4M | $772.5M | $754.1M | $289.4M | $399.2M | $429.8M | $459.3M | $492.4M | $511.2M | $527.8M | $257.8M | $269.5M | $279.3M | $166.0M | $174.8M | $183.9M | $193.3M | $202.1M | $210.1M | $149.0M | $127.4M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $13.2M | $12.5M | $9.0M | $14.5M | $2.5M | $3.3M | -$1.7M | -$1.1M | -$2.7M | -$14.0M | -$12.2M | -$9.3M | $400.0K | $700.0K | $1.0M | $3.2M | $4.6M | -$1.4M | $1.6M | $645.0K | -$233.0K | -$2.1M | -$2.8M | -$3.7M | -$534.0K | -$713.0K | -$235.0K | -$187.0K | -$39.0K | -$188.0K | -$609.0K | -$404.0K | -$179.0K | -$207.0K | -$126.0K | -$194.0K | -$9.0K | -$44.0K | -$44.0K | $19.0K | -$143.0K | -$127.0K | -$159.0K | -$19.0K | ||||||
| Other Assets Current | $68.2M | $120.7M | $119.3M | $121.7M | $120.2M | $100.5M | $108.2M | $100.6M | $113.2M | $67.9M | $62.7M | $60.8M | $50.5M | $38.4M | $33.8M | $34.7M | $27.5M | $26.7M | $23.0M | $21.5M | $24.2M | $18.9M | $16.3M | $8.6M | $7.4M | $5.5M | $3.9M | $4.8M | $4.6M | $4.4M | $5.9M | $4.7M | $4.9M | $4.2M | $2.2M | $2.1M | $2.2M | $2.7M | $2.2M | $2.1M | $2.1M | $2.0M | ||||||||
| Other Liabilities Noncurrent | $195.7M | $210.1M | $181.6M | $135.0M | $141.1M | $120.5M | $68.6M | $88.5M | $41.3M | $17.1M | $28.0M | $19.7M | $8.3M | $29.0M | $21.3M | $4.3M | $27.1M | $21.6M | $11.7M | $17.9M | $15.9M | $113.0K | $113.0K | $113.0K | $113.0K | $113.0K | $221.0K | $220.0K | $245.0K | $260.0K | $260.0K | $260.0K | $260.0K | $152.0K | $152.0K | $152.0K | $152.0K | $151.0K | $124.0K | $124.0K | $101.0K | |||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $4.6M | $7.1M | $2.1M | $290.0K | -$512.0K | -$269.0K | -$1.4M | -$1.0M | -$617.0K | -$639.0K | -$623.0K | -$501.0K | ||||||||||||||||||||||||||||||||||||||
| Deferred Gain On Sale Of Real Estate | $183.0K | $201.0K | $183.0K | $879.0K | $879.0K | $853.0K | $854.0K | $853.0K | $828.0K | $829.0K | $830.0K | $805.0K | $805.0K | $804.0K | $781.0K | $781.0K | $782.0K | $759.0K | $759.0K | $758.0K | $736.0K | $737.0K | $736.0K | $715.0K | $715.0K | |||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||||||||
| Additional Paid In Capital Common Stock | $2.70B | $2.60B | $2.53B | $2.62B | $2.56B | $2.50B | $2.31B | $2.24B | $2.17B | $2.05B | $2.00B | $1.95B | $1.97B | $1.93B | $1.90B | $1.87B | $1.84B | $1.80B | $1.74B | $1.70B | $1.68B | $1.65B | $1.63B | $1.61B | $1.55B | $1.54B | $1.38B | $1.36B | $1.36B | $1.35B | $1.33B | |||||||||||||||||||
| Equity Securities Fv Ni Unrealized Gain Loss | $30.6M | -$6.7M | -$30.6M | -$16.9M | -$19.9M | $1.6M | -$40.1M | $37.3M | $2.2M | $11.1M | -$7.4M | $19.9M | -$8.2M | $0.00 | $700.0K | -$7.0M | $11.3M | -$16.5M | -$28.5M | $21.0M | $1.7M | |||||||||||||||||||||||||||||
| Restricted Cash And Cash Equivalents Noncurrent | $3.2M | $3.2M | $3.2M | $3.2M | $3.2M | $4.7M | $5.5M | $5.5M | $5.5M | $5.5M | $4.5M | $4.6M | $4.6M | $5.1M | $4.9M | $4.9M | $5.0M | $4.8M | $4.8M | $4.8M | $4.4M | $4.4M | $4.4M | $4.3M | $4.3M | $4.3M | $4.3M | $4.3M | $4.3M | $6.1M | $6.1M | |||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $584.3M | $489.5M | $475.2M | $392.7M | $358.5M | $417.2M | $503.0M | $391.6M | $355.7M | $297.8M | $265.7M | $235.9M | $205.9M | $190.9M | $171.9M | $170.5M | $137.1M | $125.9M | $102.4M | $95.0M | $68.3M | $72.0M | $61.0M | $45.7M | $37.3M | $26.8M | ||||||||||||||||||||||||
| Accounts Receivable Net Current | $728.0M | $595.7M | $516.0M | $481.1M | $468.2M | $450.7M | $417.8M | $387.6M | $391.6M | $350.0M | $301.2M | $279.0M | $263.5M | $163.8M | $158.5M | $147.8M | $156.9M | $148.4M | $148.6M | $115.3M | $95.4M | $72.0M | $54.1M | $42.6M | $44.6M | $29.8M | $6.1M | |||||||||||||||||||||||
| Other Liabilities Current | $53.7M | $56.8M | $47.7M | $37.0M | $40.0M | $36.7M | $18.7M | $21.2M | $18.4M | $18.1M | $20.0M | $17.6M | $20.0M | $22.0M | $18.1M | $15.5M | $16.4M | $14.4M | $13.3M | $5.6M | $3.7M | $731.0K | $731.0K | $85.0K | ||||||||||||||||||||||||||
| Deferred Rent Credit Noncurrent | $0.00 | $18.1M | $12.1M | $5.3M | $3.1M | $3.2M | $1.7M | $1.3M | $1.6M | $1.7M | $1.8M | $1.8M | $1.9M | $1.8M | $1.9M | $1.9M | $2.0M | $2.0M | $1.9M | $1.9M | $2.0M | $2.0M | $1.9M | $1.7M | $1.6M | |||||||||||||||||||||||||
| Deferred Gain On Sale Of Real Estate Noncurrent | $0.00 | $7.3M | $7.5M | $7.7M | $7.9M | $8.2M | $8.4M | $6.5M | $8.3M | $9.1M | $10.0M | $11.8M | $12.6M | $13.5M | $15.2M | $16.0M | $16.8M | $18.5M | $19.3M | $20.1M | $21.7M | $22.4M | $23.2M | $24.8M | $25.5M | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$38.9M | $145.2M | -$159.1M | -$66.0M | $165.5M | $74.7M | -$68.9M | -$79.4M | ||||||||||||||||||||||||||||||||||||||||||
| Other Operating Activities Cash Flow Statement | $7.9M | $3.4M | -$100.0K | $800.0K | $2.6M | $400.0K | -$200.0K | -$229.0K | ||||||||||||||||||||||||||||||||||||||||||
| Gains Losses On Sales Of Assets | $201.0K | $879.0K | $856.0K | $839.0K | $794.0K | $795.0K | $783.0K | $816.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$38.3M | -$486.7M | $65.3M | -$234.3M | $27.4M | -$157.8M | $32.4M | $29.5M | $516.6M | $2.4M | $277.0M | $138.7M | $5.3M | $83.7M | $286.0K | $21.5M | $9.9M |
| Investing Cash Flow * | -$264.4M | -$126.8M | -$467.1M | -$177.1M | -$130.2M | $4.1M | -$211.1M | -$242.9M | -$251.3M | $113.0M | -$195.8M | -$105.4M | $5.3M | -$34.8M | -$3.5M | -$54.7M | $12.1M |
| Operating Cash Flow * | $782.7M | $595.4M | $389.9M | $339.4M | $256.5M | $228.5M | $147.0M | $101.4M | -$94.3M | -$106.2M | -$38.0M | -$47.1M | -$29.6M | -$35.3M | -$698.0K | $49.9M | -$53.1M |
| Proceeds From Issuance Of Common Stock | $129.4M | $122.1M | $65.3M | $44.7M | $27.5M | $29.1M | $32.4M | $29.5M | $13.9M | $2.4M | $277.0M | $138.7M | $5.3M | $83.7M | $286.0K | $21.5M | $9.9M |
| Share Based Compensation | $217.9M | $195.5M | $194.3M | $173.1M | $134.2M | $100.0M | $75.3M | $58.1M | $42.5M | $28.5M | $28.4M | $10.4M | $6.8M | $5.5M | $2.9M | $3.1M | $5.5M |
| Payments To Acquire Property Plant And Equipment | $34.0M | $38.2M | $28.3M | $16.5M | $23.4M | $10.9M | $14.7M | $24.8M | $6.9M | $4.1M | $1.9M | $1.6M | $545.0K | $971.0K | $750.0K | $315.0K | $35.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $160.2M | $43.4M | $49.0M | $114.6M | $56.8M | $26.9M | $54.0M | $24.2M | $27.3M | $4.4M | $9.8M | $3.7M | -$949.0K | -$557.0K | $149.0K | $985.0K | -$4.1M |
| Stock Issued During Period Value Share Based Compensation | $127.3M | $122.1M | $65.3M | $44.7M | $27.5M | $29.1M | $32.4M | $0.00 | $1.0K | $0.00 | $1.0K | $0.00 | $0.00 | $0.00 | $1.0K | ||
| Increase Decrease In Accounts Receivable | $210.5M | $39.8M | $89.3M | $162.2M | $28.4M | $30.5M | $69.2M | $25.1M | $31.1M | $0.00 | $0.00 | ||||||
| Proceeds From Sale Of Property Plant And Equipment | $8.0K | $34.0K | $7.0K | $13.0K | $9.0K | $45.0K | $40.0K | $32.0K | $245.0K | $336.0K | $1.2M | ||||||
| Increase Decrease In Inventories | $15.3M | $19.1M | -$5.4M | $2.6M | $2.5M | $10.7M | $6.4M | $3.5M | $1.0M | $0.00 | $0.00 | ||||||
| Payments To Acquire Investments | $546.0M | $583.4M | $298.8M | $449.1M | $257.5M | $145.3M | $166.3M | $139.1M | $89.8M | $16.8M | |||||||
| Increase Decrease In Cease Use Liability | -$247.0K | -$300.0K | -$610.0K | -$418.0K | -$590.0K | -$263.0K | -$7.5M | -$4.5M | -$9.9M | ||||||||
| Increase Decrease In Deferred Liabilities | $351.0K | $1.2M | -$294.0K | -$16.0K | $14.0K | $142.0K | $305.0K | $434.0K | $680.0K | $796.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$117.9M | $69.9M | $8.2M | $6.1M | $15.1M | $6.0M | $2.6M | $16.1M | $1.5M | $62.0K | $273.5M | $136.2M | $966.0K | $83.3M | $57.0K | ||||||||||||||||
| Investing Cash Flow * | $14.2M | -$55.0M | -$42.1M | -$31.6M | $63.1M | $33.2M | $41.0M | -$57.1M | $56.8M | $70.3M | -$116.1M | -$65.7M | -$35.1M | -$45.2M | -$21.1M | ||||||||||||||||
| Operating Cash Flow * | $64.8M | $130.3M | -$125.2M | -$40.5M | $87.3M | $35.5M | -$112.5M | -$38.5M | -$77.4M | -$29.2M | -$18.2M | -$9.8M | $1.9M | -$11.2M | -$8.6M | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | $32.1M | $69.9M | $8.2M | $6.1M | $15.2M | $6.0M | $2.6M | $16.1M | $1.5M | $62.0K | $273.5M | $136.2M | $966.0K | $83.3M | $57.0K | ||||||||||||||||
| Share Based Compensation | $52.8M | $44.5M | $39.9M | $37.0M | $32.9M | $22.8M | $15.8M | $19.9M | $9.0M | $6.9M | $3.6M | $2.4M | $1.7M | $1.4M | $712.0K | ||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $10.7M | $11.2M | $8.5M | $7.6M | $4.5M | $1.3M | $3.9M | $1.8M | $1.4M | $741.0K | $280.0K | $255.0K | $59.0K | $404.0K | $20.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $12.4M | -$18.6M | $6.7M | $11.5M | $11.0M | -$16.2M | -$16.6M | -$7.9M | -$6.9M | -$2.3M | -$546.0K | -$1.1M | -$968.0K | -$2.0M | -$3.0M | ||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $45.4M | $12.5M | $32.1M | $26.4M | $15.8M | $69.9M | $18.8M | $2.9M | $8.2M | $11.4M | $2.6M | $6.1M | $7.5M | $3.0M | $15.2M | $5.4M | $15.8M | $6.0M | |||||||||||||
| Increase Decrease In Accounts Receivable | $36.9M | $11.3M | $41.7M | $78.0M | -$9.3M | $22.1M | $15.7M | $13.5M | $779.0K | ||||||||||||||||||||||
| Proceeds From Sale Of Property Plant And Equipment | $4.0K | $18.0K | $0.00 | $3.0K | $9.0K | $40.0K | $13.0K | $25.0K | $83.0K | ||||||||||||||||||||||
| Increase Decrease In Inventories | $1.7M | -$1.1M | -$1.8M | -$1.5M | $2.1M | $3.9M | $1.8M | $309.0K | |||||||||||||||||||||||
| Payments To Acquire Investments | $116.3M | $139.4M | $57.9M | $55.6M | $159.2M | $108.9M | $66.5M | $75.4M | $50.6M | ||||||||||||||||||||||
| Increase Decrease In Cease Use Liability | -$62.0K | -$66.0K | -$110.0K | -$113.0K | -$102.0K | -$194.0K | -$64.0K | -$65.0K | -$64.0K | -$729.0K | -$1.2M | -$1.2M | |||||||||||||||||||
| Increase Decrease In Deferred Liabilities | -$28.0K | -$114.0K | -$64.0K | -$27.0K | $6.0K | $38.0K | $80.0K | $99.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $4.67 | $3.29 | $2.47 | $1.56 | $0.92 | $4.16 | $0.39 | $0.22 | -$1.62 | -$1.63 | -$1.05 | -$0.81 | -$0.69 | $0.08 | $0.67 | -$0.15 | -$1.30 |
| Weighted Average Number Of Shares Outstanding Basic | 99.5M | 100.4M | 97.7M | 95.8M | 94.6M | 93.1M | 91.6M | 90.2M | 88.1M | 86.7M | 84.5M | 74.6M | 67.0M | 65.6M | 55.2M | 52.8M | 39.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 102.5M | 103.7M | 101.0M | 98.9M | 97.9M | 97.8M | 95.7M | 95.4M | 88.1M | 86.7M | 84.5M | 74.6M | 67.0M | 66.9M | 56.3M | 52.8M | 39.1M |
| Earnings Per Share Basic | $4.81 | $3.40 | $2.56 | $1.61 | $0.95 | $4.38 | $0.40 | $0.23 | $-1.62 | $-1.63 | $-1.05 | $-0.81 | $-0.69 | $0.08 | $0.68 | $-0.15 | $-1.30 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 100.1M | 99.4M | 98.7M | 96.5M | 94.9M | 93.5M | 92.3M | 90.8M | 88.8M | 86.9M | 86.3M | 76.5M | 67.4M | 66.4M | 55.3M | 54.9M | |
| Common Stock Shares Issued | 100.1M | 99.4M | 98.7M | 96.5M | 94.9M | 93.5M | 92.3M | 90.8M | 88.8M | 86.9M | 86.3M | 76.5M | 67.4M | 66.4M | 55.3M | 54.9M | |
| Common Stock Shares Authorized | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q4 2010 | Q3 2010 | Q2 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $2.04 | $1.06 | $0.08 | $1.24 | $0.63 | $0.42 | $0.82 | $0.95 | -$0.79 | $0.69 | -$0.18 | $0.14 | $0.23 | $0.43 | $0.33 | $3.58 | -$0.62 | $0.81 | $0.39 | $0.35 | $0.56 | $0.54 | -$1.12 | $0.19 | $0.52 | -$0.07 | -$0.47 | $0.07 | -$0.13 | -$0.68 | -$0.90 | -$0.43 | -$0.46 | -$0.22 | -$0.40 | -$0.28 | -$0.01 | -$0.21 | -$0.18 | -$0.17 | -$0.16 | -$0.17 | -$0.18 | -$0.18 | $0.14 | -$0.05 | -$0.01 | -$0.01 | $0.02 | $0.56 | $0.04 | $0.05 | $0.06 | -$0.09 | |
| Weighted Average Number Of Shares Outstanding Basic | 99.4M | 99.0M | 99.7M | 101.1M | 100.8M | 99.8M | 97.9M | 97.6M | 97.1M | 95.8M | 95.6M | 95.3M | 94.7M | 94.6M | 94.2M | 93.5M | 93.3M | 93.0M | 92.6M | 92.2M | 91.9M | 91.4M | 91.1M | 90.7M | 90.6M | 90.1M | 89.5M | 88.7M | 88.3M | 88.1M | 87.3M | 67.3M | 67.2M | 66.8M | 66.6M | 66.4M | 66.3M | 66.3M | 63.4M | 55.3M | 55.2M | 55.2M | 55.0M | 54.8M | 54.8M | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 102.5M | 101.0M | 102.5M | 104.3M | 103.9M | 103.6M | 101.1M | 100.2M | 97.1M | 99.0M | 95.6M | 97.6M | 97.7M | 97.7M | 98.2M | 97.2M | 93.3M | 98.2M | 97.0M | 97.2M | 96.1M | 94.8M | 91.1M | 95.7M | 96.8M | 90.1M | 89.5M | 92.7M | 88.3M | 88.1M | 87.3M | 67.3M | 67.2M | 66.8M | 66.6M | 67.7M | 66.3M | 66.3M | 63.4M | 56.5M | 56.4M | 56.4M | 56.1M | 55.6M | 54.8M | ||||||||||
| Earnings Per Share Basic | $2.11 | $1.09 | $0.08 | $1.28 | $0.64 | $0.43 | $0.85 | $0.98 | $-0.79 | $0.72 | $-0.18 | $0.15 | $0.24 | $0.45 | $0.34 | $3.72 | $-0.62 | $0.86 | $0.40 | $0.37 | $0.59 | $0.56 | $-1.12 | $0.20 | $0.56 | $-0.07 | $-0.47 | $0.08 | $-0.13 | $-0.68 | $-0.90 | $-0.16 | $-0.17 | $-0.18 | $-0.18 | $0.14 | $-0.05 | $-0.01 | $-0.01 | $0.02 | $0.57 | $0.04 | $0.05 | $0.06 | $-0.09 | ||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Common Stock Shares Outstanding | 99.7M | 99.0M | 99.0M | 101.2M | 100.9M | 100.6M | 98.2M | 97.6M | 97.5M | 96.1M | 95.6M | 95.5M | 94.8M | 94.6M | 94.5M | 93.4M | 93.2M | 92.8M | 92.1M | 91.5M | 91.3M | 90.7M | 90.4M | 89.9M | 88.5M | 88.2M | 87.5M | 86.9M | 86.8M | 86.6M | 85.9M | 85.8M | 85.4M | 76.0M | 75.9M | 75.9M | 67.3M | 67.0M | 66.7M | 66.4M | 66.3M | 66.3M | 55.3M | 55.2M | |||||||||||
| Common Stock Shares Issued | 99.7M | 99.0M | 99.0M | 101.2M | 100.9M | 100.6M | 98.2M | 97.6M | 97.5M | 96.1M | 95.6M | 95.5M | 94.8M | 94.6M | 94.5M | 93.4M | 93.2M | 92.8M | 92.1M | 91.5M | 91.3M | 90.7M | 90.4M | 89.9M | 88.5M | 88.2M | 87.5M | 86.9M | 86.8M | 86.6M | 85.9M | 85.8M | 85.4M | 76.0M | 75.9M | 75.9M | 67.3M | 67.0M | 66.7M | 66.4M | 66.3M | 66.3M | 55.3M | 55.2M | |||||||||||
| Common Stock Shares Authorized | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 220.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | 110.0M | |||||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $217.9M | $195.5M | $194.3M | $173.1M | $134.2M | $100.0M | $75.3M | $58.1M | $42.5M | $28.5M | $28.4M | $10.4M | $6.8M | $5.5M | $2.9M | $3.1M | $5.5M |
| Investment Income And Other Net | $90.3M | $91.0M | $52.8M | $4.1M | $3.8M | $12.6M | $19.2M | $15.5M | $8.3M | $6.3M | |||||||
| Investment Income Net | $6.2M | $2.8M | $1.9M | $629.0K | $402.0K | $489.0K | $418.0K | $1.5M | -$1.5M | ||||||||
| Depreciation And Amortization | $4.0M | $2.4M | $1.5M | $1.0M | $827.0K | $671.0K | $657.0K | $694.0K | $1.4M | $3.2M | |||||||
| Costs And Expenses | $2.24B | $1.78B | $1.64B | $1.24B | $1.03B | $882.9M | |||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $2.2M | $2.2M | $2.5M | $700.0K | $1.9M | $1.4M | $1.0M | $2.3M | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $53.7M | $52.8M | $52.8M | $41.5M | $43.1M | $44.5M | $47.8M | $68.5M | $39.9M | $43.1M | $49.5M | $37.0M | $37.1M | $28.6M | $32.9M | $26.7M | $29.5M | $22.8M | $20.3M | $17.9M | $15.8M | $13.1M | $11.9M | $19.9M | |||||||||||||||||||||
| Investment Income And Other Net | $22.2M | $20.6M | $21.7M | $23.4M | $22.8M | $22.3M | $14.5M | $10.7M | $9.8M | $200.0K | $1.6M | $1.0M | $800.0K | $900.0K | $1.4M | $2.7M | $3.6M | $4.7M | $4.8M | $4.6M | $4.6M | $4.1M | $3.5M | $3.1M | $2.2M | $1.2M | |||||||||||||||||||
| Investment Income Net | $2.9M | $2.0M | $1.2M | $727.0K | $705.0K | $680.0K | $737.0K | $581.0K | $506.0K | $257.0K | $176.0K | $167.0K | $89.0K | $93.0K | $121.0K | $103.0K | $123.0K | $115.0K | $121.0K | $102.0K | $120.0K | $119.0K | |||||||||||||||||||||||
| Depreciation And Amortization | $1.6M | $786.0K | $489.0K | $276.0K | $244.0K | $178.0K | $175.0K | $152.0K | $240.0K | ||||||||||||||||||||||||||||||||||||
| Costs And Expenses | $555.9M | $541.9M | $549.0M | $438.3M | $444.8M | $416.0M | $357.6M | $379.1M | $534.6M | $300.1M | $323.5M | $307.5M | $251.5M | $226.1M | $205.1M | $302.8M | $225.8M | $178.2M | $132.0M | $149.1M | |||||||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $2.7M | $1.1M | $600.0K | $2.8M | $100.0K | $800.0K | $600.0K | $0.00 |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.